Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
No significant difference seen in urodynamic testing results between TPTNS and rTMS groups
Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women
Authors say findings do not support routine hormone use in the perimenopausal and postmenopausal periods
Transurethral Fulguration Alleviates Pelvic Pain in Interstitial Cystitis
Pain control was achieved by TUF in 70.0 percent of 240 patients; 18 patients underwent cystectomy for intractable pain
Urinary Incontinence Linked to CVD Risk Factors, Comorbid Conditions
No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, stroke
Antibiotic Noninferior to Ceftriaxone + Azithromycin for Gonorrhea
Neither treatment group had bacterial persistence of urogenital Neisseria gonorrhoeae at test-of-cure
CDC Shuts Down Key Labs for Hepatitis and STI Testing After Layoffs
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76
CT Exams in 2023 Projected to Result in 103,000 Future Cancers
Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers
Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
Targeted screening to participants in ≥90th percentile of polygenic risk score results in detection of cancer warranting clinical management in 55.1 percent
Recommendations Updated for Fertility Preservation in Cancer
Patients interested in or uncertain about fertility preservation should be referred to reproductive specialists
